Table S1 presenting bacteriological microorganisms obtained from culture of endotracheal aspirates or bronchoalveolar lavages from patients with confirmed pneumonia. (DOCX 15 kb
Screenshot of COSARA central infection dashboard view. Time-graphs at the top of the page show the e...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccinat...
Figure S1 showing ROC analysis of the PEEP level on day 1 with regard to the prediction of confirmed...
Table S1. Methods for diagnostic approach. Additional data about diagnostic methods stratified by pa...
Table S2. Comparison between patients who did invasive sampling while receiving or not receiving inv...
Additional file 1: Table S1. Microbiological investigation available in our center
Table S1. Frequency of MDR or non-MDR isolates in HAP cases with or without MDR risk factors. Table ...
The clinical and laboratory features of patients with pneumonia/lung abscess with pleural effusion a...
Table S1. Microorganism distribution of positive catheter tip culture and sBSI in the ICU. (DOCX 16 ...
Table S1. Microbiological Isolations. Table S2. Internal Validation of the Multivariate Logistic Reg...
Antibiotic initiation process mapping guide. A data collection tool used during antibiotic initiatio...
Figure S2. Funnel plots for the rate of (A) clinical recovery, (B) microbiological eradication, (C) ...
PRISMA checklist of items to include when reporting a systematic review and a network meta-analysis....
Figure S1. Forest plots showing the effect of aerosolized antibiotics on (A) clinical recovery, (B) ...
Screenshot of COSARA central infection dashboard view. Time-graphs at the top of the page show the e...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccinat...
Figure S1 showing ROC analysis of the PEEP level on day 1 with regard to the prediction of confirmed...
Table S1. Methods for diagnostic approach. Additional data about diagnostic methods stratified by pa...
Table S2. Comparison between patients who did invasive sampling while receiving or not receiving inv...
Additional file 1: Table S1. Microbiological investigation available in our center
Table S1. Frequency of MDR or non-MDR isolates in HAP cases with or without MDR risk factors. Table ...
The clinical and laboratory features of patients with pneumonia/lung abscess with pleural effusion a...
Table S1. Microorganism distribution of positive catheter tip culture and sBSI in the ICU. (DOCX 16 ...
Table S1. Microbiological Isolations. Table S2. Internal Validation of the Multivariate Logistic Reg...
Antibiotic initiation process mapping guide. A data collection tool used during antibiotic initiatio...
Figure S2. Funnel plots for the rate of (A) clinical recovery, (B) microbiological eradication, (C) ...
PRISMA checklist of items to include when reporting a systematic review and a network meta-analysis....
Figure S1. Forest plots showing the effect of aerosolized antibiotics on (A) clinical recovery, (B) ...
Screenshot of COSARA central infection dashboard view. Time-graphs at the top of the page show the e...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccinat...